Found: 7
Select item for more details and to access through your institution.
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. 1624, doi. 10.1093/cid/ciaa1365
- By:
- Publication type:
- Article
Legends of allergy and immunology: Monique Capron.
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 937, doi. 10.1111/all.14501
- By:
- Publication type:
- Article
Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 8, p. 1017, doi. 10.1093/cid/cix016
- By:
- Publication type:
- Article
A Functional γδTCR/CD3 Complex Distinct from γδT Cells Is Expressed by Human Eosinophils.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005926
- By:
- Publication type:
- Article
Involvement of eosinophils in the anti-tumor response.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 9, p. 1527, doi. 10.1007/s00262-012-1288-3
- By:
- Publication type:
- Article
Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection.
- Published in:
- Nature Medicine, 2013, v. 19, n. 6, p. 713, doi. 10.1038/nm.3189
- By:
- Publication type:
- Article
Siglec‐7 on peripheral blood eosinophils: Surface expression and function.
- Published in:
- Allergy, 2019, v. 74, n. 7, p. 1257, doi. 10.1111/all.13730
- By:
- Publication type:
- Article